Page 149 - Read Online
P. 149

activity. [43]  The presence of neuroinflammation and   Chronic treatment with ibuprofen reduced microglial
           its  contribution  to  cognitive  and  motor  alterations   activation and inflammatory markers and restored
           have also been demonstrated in the other main animal   the  function  of  the  glutamate-NO-cGMP  pathway
           model of MHE: rats with bile duct ligation  (BDL).   in cerebellum and cognitive and motor functions in
           Rodrigo et al. [45]  showed that BDL rats have microglial   hyperammonemic rats. [44]  In summary, this indicates
           activation, mainly in  cerebellum,  as demonstrated   that: (1) chronic hyperammonemia  per se induces
           by immunohistochemistry. This is associated with   neuroinflammation; (2) neuroinflammation mediates
           increased levels of inflammatory markers [inducible   the  effects  of  chronic  hyperammonemia  on  the
           nitric oxide synthase (iNOS), IL-1β, prostaglandin E2]   function of the glutamate-NO-cGMP pathway in
           and with cognitive impairment and hypokinesia.     cerebellum and on cognitive and motor functions in
           Similar to the previous studies, chronic treatment   hyperammonemic rats. As neurological  alterations
           with ibuprofen reduced microglial activation and   are mainly due to altered glutamatergic and
           inflammatory  markers  and restored  cognitive and   GABAergic neurotransmission, [48,49]  this suggests
           motor functions in the BDL rats. [45]  The above reports   that neuroinflammation-mediated alterations in
           clearly support the idea that MHE in chronic liver   neurotransmission are mainly responsible for changes
           failure  is  associated  with  neuroinflammation  that   in cognitive and motor function in MHE and clinical
           affects different cerebral processes resulting in different   HE [Figure 1].
           types of cognitive and motor alterations [Figure 1].
                                                              Hyperammonemia may also alter neurotransmission by
           CHRONIC HYPERAMMONEMIA INDUCES                     other mechanisms. For example, Thrane et al. [50]  have
           ACTIVATION OF MICROGLIA AND                        shown that ammonia, at high concentrations, alters
           NEUROINFLAMMATION                                  astrocyte potassium buffering, increasing extracellular
                                                              potassium concentration and over-activating the
                                                                 +
                                                                    +
           Concerning the mechanisms by which chronic liver   Na -K -2Cl   co-transporter  isoform  1  (NKCC1)  in
                                                                         −
           failure induces neuroinflammation, it seems that   neurons. The consequent depolarization of the
           two main contributors would be involved: chronic   neuronal GABA reversal potential selectively impairs
           hyperammonemia and peripheral inflammation.        cortical inhibitory networks. This altered GABAergic
                                                              neurotransmission may contribute to the neurological
           In addition to PCS and BDL rats, a well-recognized   alterations in hyperammonemia. The alterations in
           rodent model of MHE are rats with “pure”           glutamatergic and GABAergic neurotransmission in
           hyperammonemia without liver failure induced by    hyperammonemia and HE have been recently reviewed
           feeding an ammonium-containing diet. [41]  As described   by Cauli et al. [48]  In addition to the contribution of
           above for rat model of MHE induced by PCS, rats    hyperammonemia, peripheral inflammation  would
           with chronic hyperammonemia also show reduced      also contribute to induction of neuroinflammation in
           function of the glutamate-NO-cGMP pathway in       chronic liver disease [Figure 1].
           cerebellum [46]  and reduced ability to learn the Y maze
           task, [47]  which is restored when the function of the   The mechanisms by which hyperammonemia induces
           pathway is restored, for example, by treatment with   microglial activation and neuroinflammation have
           sildenafil. [42]  This suggests that hyperammonemia   been poorly studied for the moment. Zemtsova et al. [36]
           and neuroinflammation impair learning the ability by   studied the effects of large ammonia concentrations
           the same mechanism. This idea led Rodrigo et al. [45]    on rat microglia in vitro and in vivo. In cultured rat
           to hypothesize that hyperammonemia would induce    microglia, ammonia-stimulated cell migration and
           neuroinflamamtion in the brain, which would be     induced oxidative stress and an up-regulation of the
           responsible for impairment of the glutamate-NO-cGMP   microglial activation marker ionized calcium-binding
           pathway and of cognitive function. To assess       adaptor  molecule-1  (Iba-1).  Up-regulation  of  Iba-1
           whether chronic hyperammonemia per se induces      was also found in the cerebral cortex from acutely
           neuroinflammation, Rodrigo et al. [45]  assessed in the   ammonia-intoxicated rats. However, ammonia had no
           brains of hyperammonemic rats without liver failure   effect on microglial glutamate release, prostaglandin
           activation of microglia by immunohistochemistry    synthesis, and messenger RNA (mRNA) levels of iNOS,
           and the levels of inflammatory markers [iNOS, IL-1β,   COX-2, and IL-1a/β, tumor necrosis factor a (TNFa),
           and  prostaglandin  E  2  (PGE2)].  Hyperammonemic   or IL-6, whereas in cultured astrocytes ammonia
           rats show microglial activation [Figure 1], mainly in   induced the release of glutamate, prostaglandins,
           cerebellum, and increased levels of inducible iNOS,   and increased levels of IL-1β mRNA. Although this
           IL-1β, and PGE2 which are associated with impaired   study was performed using ammonia levels much
           function of the glutamate-NO-cGMP pathway          higher than those that can be found in chronic liver
           and with cognitive impairment and hypokinesia.     disease in vivo, these data suggest that ammonia per se


   140  Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015  Neuroimmunol Neuroinflammation | Volume 2 | Issue 3 | July 15, 2015   141
   144   145   146   147   148   149   150   151   152   153   154